Search
Feed aggregator
Do You Need to Love Your Job to Be Happy at Your Job?
Do You Need to Love Your Job to Be Happy at Your Job? 5/23/2024
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030 5/21/2024
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea 5/21/2024
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology 5/21/2024
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms 5/21/2024
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials 5/21/2024
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate 5/21/2024
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act 5/21/2024
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer 5/17/2024
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B 5/17/2024
Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts
Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts 5/17/2024
Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul
Bayer’s 1,500 Layoffs Are Latest Salvo in CEO Bill Anderson’s Company Overhaul 5/17/2024
EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA
EU Regulator Pulls Approval for Preterm Labor Drug One Year After FDA 5/17/2024
Bayer Touts Phase III Results for Menopause Symptom Drug
Bayer Touts Phase III Results for Menopause Symptom Drug 5/17/2024
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines 5/17/2024
J&J Buys Proteologix for $850M, Bispecific Antibodies for Atopic Dermatitis
J&J Buys Proteologix for $850M, Bispecific Antibodies for Atopic Dermatitis 5/16/2024
Lilly’s Weekly Insulin Scores Late-Stage Win as Race With Novo Heats Up
Lilly’s Weekly Insulin Scores Late-Stage Win as Race With Novo Heats Up 5/16/2024
Sanders Warns Weight-Loss Drugs Could Bankrupt US Healthcare System
Sanders Warns Weight-Loss Drugs Could Bankrupt US Healthcare System 5/16/2024
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candid...
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candid... 5/16/2024
BMS CAR-T Therapy Wins FDA Approval for Expanded Use in Follicular Lymphoma
BMS CAR-T Therapy Wins FDA Approval for Expanded Use in Follicular Lymphoma 5/16/2024
World Pharma News
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
- A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
- Common gout drug may reduce risk of heart attack and stroke
- New nasal vaccine has potential to transform respiratory disease prevention
- MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs